DNA-methylation analysis of differentially expressed genes in fibroblast cell-lines, derived from monozygotic twins discordant for Parkinson’s disease
Abstract
In recent years it has been convincingly demonstrated that genetic factors play an important role in progression of Parkinson’s disease (PD). Since the etiology of PD has not been elucidated completely yet, it is crucial to shift focus of the research to the broader areas - to dive into investigations of methylome and transcriptome. Epigenetic regulation of gene expression may take part in pathogenesis of PD. Changes in epigenome can be conveniently investigated in case of individuals with almost identical genetic makeup, and monozygotic twins discordant for PD may be such “model”. 3 pairs phenotypically and genotypically monozygous twins of Russian ancestry were enrolled in the study. PD was diagnosed in one of each pair. The disease duration was at least 7 years. Data on blood methylomes was analyzed. Points of variable methylation in blood methylomes were selected. With this approach, 8 differentially expressed genes were found that also may be differentially methylated. Changes in methylation level for some of this genes were found in monozygotic twins discordant for PD fibroblasts cell-lines between healthy and afflicted siblings. Acquired data might suggest participation of DNA-methylation in transcription regulation of PD pathogenesis-related candidate genes.
About the Authors
I. N. Rybolovlev
Institute of Molecular Genetics of the Russian Academy of Sciences
Russian Federation
I. N. Vlasov
Institute of Molecular Genetics of the Russian Academy of Sciences
Russian Federation
A. Kh. Alieva
Institute of Molecular Genetics of the Russian Academy of Sciences
Russian Federation
P. A. Slominskiy
Institute of Molecular Genetics of the Russian Academy of Sciences
Russian Federation
M. I. Shadrina
Institute of Molecular Genetics of the Russian Academy of Sciences
Russian Federation
References
1. Lesage S., Brice A. Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genetю. 2009; 18(R1): R48-59.
2. Kalia L.V., Lang A.E. Parkinson’s disease. Lance. 2015; 386(9996): 896-912.
3. Singleton A.B., Farrer M.J., Bonifati V. The genetics of Parkinson’s disease: progress and therapeutic implications. Mov Disord. 2013; 28(1): 14-23.
4. Soldner F. et al. Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression. Nature. 2016; 533(7601): 95-9.
For citations:
Rybolovlev I.N.,
Vlasov I.N.,
Alieva A.Kh.,
Slominskiy P.A.,
Shadrina M.I.
DNA-methylation analysis of differentially expressed genes in fibroblast cell-lines, derived from monozygotic twins discordant for Parkinson’s disease. Medical Genetics. 2020;19(12):73-74.
(In Russ.)
Views:
444